Evaluation of animal models for intestinal first-pass metabolism of drug candidates to be metabolized by CYP3A enzymes via in vivo and in vitro oxidation of midazolam and triazolam

By Kuze J.  

Xenobiotica, Vol. 43, Iss. 7, 2013-07 ,pp. : 598-606

Informa Healthcare

Access to resources Recommend Favorite

Model for the drug-drug interaction responsible for CYP3A enzyme inhibition. II: establishment and evaluation of dexamethasone-pretreated female rats

By Kanazu T.   Yamaguchi Y.   Okamura N.   Baba T.   Koike M.  

Xenobiotica, Vol. 34, Iss. 5, 2004-05 ,pp. : 403-413

Informa Healthcare

Access to resources Recommend Favorite

Model for the drug-drug interaction responsible for CYP3A enzyme inhibition. I: evaluation of cynomolgus monkeys as surrogates for humans

By Kanazu T.   Yamaguchi Y.   Okamura N.   Baba T.   Koike M.  

Xenobiotica, Vol. 34, Iss. 5, 2004-05 ,pp. : 391-402

Informa Healthcare

Access to resources Recommend Favorite

Enzymatic characteristics of CYP3A5 and CYP3A4: A comparison of in vitro kinetic and drug–drug interaction patterns

By Emoto C.   Iwasaki K.  

Xenobiotica, Vol. 36, Iss. 2-3, 2006-02 ,pp. : 219-233

Informa Healthcare

Access to resources Recommend Favorite

Pharmacokinetics and first-pass elimination of metoprolol in rats: contribution of intestinal first-pass extraction to low bioavailability of metoprolol

By Yoon In-Soo   Choi Min-Koo   Kim Jung Sun   Shim Chang-Koo   Chung Suk-Jae   Kim Dae-Duk  

Xenobiotica, Vol. 41, Iss. 3, 2011-03 ,pp. : 243-251

Informa Healthcare

Access to resources Recommend Favorite